Table of Contents

2019-2024 Global Artemisinine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Artemisinine Consumption 2014-2024
  • 2.1.2 Artemisinine Consumption CAGR by Region
• 2.2 Artemisinine Segment by Type
  • 2.2.1 Extraction from Artemisia annua
  • 2.2.2 Semisynthetic Artemisinine
• 2.3 Artemisinine Consumption by Type
  • 2.3.1 Global Artemisinine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Artemisinine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Artemisinine Sale Price by Type (2014-2019)
• 2.4 Artemisinine Segment by Application
  • 2.4.1 Injections
  • 2.4.2 Tablets
  • 2.4.3 Others
• 2.5 Artemisinine Consumption by Application
  • 2.5.1 Global Artemisinine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Artemisinine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Artemisinine Sale Price by Application (2014-2019)

3 Global Artemisinine by Players

• 3.1 Global Artemisinine Sales Market Share by Players
  • 3.1.1 Global Artemisinine Sales by Players (2017-2019)
  • 3.1.2 Global Artemisinine Sales Market Share by Players (2017-2019)
• 3.2 Global Artemisinine Revenue Market Share by Players
  • 3.2.1 Global Artemisinine Revenue by Players (2017-2019)
  • 3.2.2 Global Artemisinine Revenue Market Share by Players (2017-2019)
• 3.3 Global Artemisinine Sale Price by Players
• 3.4 Global Artemisinine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Artemisinine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Artemisinine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Artemisinine by Regions

• 4.1 Artemisinine by Regions
  • 4.1.1 Global Artemisinine Consumption by Regions
  • 4.1.2 Global Artemisinine Value by Regions
• 4.2 Americas Artemisinine Consumption Growth
• 4.3 APAC Artemisinine Consumption Growth
• 4.4 Europe Artemisinine Consumption Growth
• 4.5 Middle East & Africa Artemisinine Consumption Growth

5 Americas

• 5.1 Americas Artemisinine Consumption by Countries
  • 5.1.1 Americas Artemisinine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Artemisinine Value by Countries (2014-2019)
• 5.2 Americas Artemisinine Consumption by Type
• 5.3 Americas Artemisinine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Artemisinine Consumption by Countries
  • 6.1.1 APAC Artemisinine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Artemisinine Value by Countries (2014-2019)
• 6.2 APAC Artemisinine Consumption by Type
• 6.3 APAC Artemisinine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Artemisinine by Countries
  • 7.1.1 Europe Artemisinine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Artemisinine Value by Countries (2014-2019)
• 7.2 Europe Artemisinine Consumption by Type
• 7.3 Europe Artemisinine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Artemisinine by Countries
  • 8.1.1 Middle East & Africa Artemisinine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Artemisinine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Artemisinine Consumption by Type
• 8.3 Middle East & Africa Artemisinine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Artemisinine Distributors
• 10.3 Artemisinine Customer

11 Global Artemisinine Market Forecast

• 11.1 Global Artemisinine Consumption Forecast (2019-2024)
• 11.2 Global Artemisinine Forecast by Regions
  • 11.2.1 Global Artemisinine Forecast by Regions (2019-2024)
  • 11.2.2 Global Artemisinine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Artemisinine Forecast by Type
• 11.8 Global Artemisinine Forecast by Application

12 Key Players Analysis

• 12.1 Guilin Pharmaceutical
  • 12.1.1 Company Details
  • 12.1.2 Artemisinine Product Offered
  • 12.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Guilin Pharmaceutical News
• 12.2 CAT KHANH
  • 12.2.1 Company Details
  • 12.2.2 Artemisinine Product Offered
  • 12.2.3 CAT KHANH Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 CAT KHANH News
• 12.3 Novanat Bioresource
  • 12.3.1 Company Details
  • 12.3.2 Artemisinine Product Offered
  • 12.3.3 Novanat Bioresource Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Novanat Bioresource News
• 12.4 BEEPZ
  • 12.4.1 Company Details
  • 12.4.2 Artemisinine Product Offered
  • 12.4.3 BEEPZ Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 BEEPZ News
• 12.5 KPC Pharmaceuticals
  • 12.5.1 Company Details
  • 12.5.2 Artemisinine Product Offered
  • 12.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 KPC Pharmaceuticals News
• 12.6 BIONEXX
  • 12.6.1 Company Details
  • 12.6.2 Artemisinine Product Offered
  • 12.6.3 BIONEXX Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 BIONEXX News
• 12.7 Guangxi xiancaotang
  • 12.7.1 Company Details
  • 12.7.2 Artemisinine Product Offered
  • 12.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Guangxi xiancaotang News
• 12.8 Sanofi
  • 12.8.1 Company Details
  • 12.8.2 Artemisinine Product Offered
  • 12.8.3 Sanofi Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Sanofi News
• 12.9 Natural Bio-engineering
  • 12.9.1 Company Details
  • 12.9.2 Artemisinine Product Offered
  • 12.9.3 Natural Bio-engineering Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Natural Bio-engineering News
• 12.10 Kerui nanhai
  • 12.10.1 Company Details
  • 12.10.2 Artemisinine Product Offered
  • 12.10.3 Kerui nanhai Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Kerui nanhai News

13 Research Findings and Conclusion

Artemisinine is a drug derived from the Asian plant Artemisia annua. This aromatic plant has fern-like leaves and yellow flowers. For more than 2,000 years, it has been used to treat fevers. It's also an effective treatment for malaria.

According to this study, over the next five years the Artemisinine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artemisinine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinine market by product type, application, key manufacturers and key regions and countries.

This study considers the Artemisinine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Extraction from Artemisia annua
Semisynthetic Artemisinine
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Injections
Tablets
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Artemisinine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Artemisinine market by identifying its various subsegments.
Focuses on the key global Artemisinine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artemisinine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artemisinine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.